RXO, Inc.RXONYSE
Loading
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Revenue | 4,689 | 4,796 | 3,927 |
| Gross Profit | 735 | 860 | 725 |
| Operating Income | 192 | 123 | 39 |
| Net Income | 150 | 92 | 4 |
| EBITDA | 272 | 209 | 134 |
| EPS Diluted | 1.30 | 0.79 | 0.03 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Cash & Equivalents | 29 | 98 | 5 |
| Total Current Assets | 1,083 | 1,029 | 796 |
| Total Assets | 2,068 | 2,031 | 1,825 |
| Total Current Liabilities | 816 | 823 | 682 |
| Total Liabilities | 998 | 1,444 | 1,231 |
| Total Equity | 1,070 | 587 | 594 |
| Total Debt | 228 | 617 | 558 |
| Net Debt | 199 | 519 | 553 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Operating Cash Flow | 155 | 310 | 89 |
| Capital Expenditure | -39 | -57 | -64 |
| Free Cash Flow | 116 | 253 | 25 |
| Stock-Based Comp | 8 | 32 | 19 |
| Net Change in Cash | -41 | 69 | -93 |